澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ONCOSIL MEDICAL LTD

1.015

+0.0353.57%

成交量：1.64萬

成交額：1.63萬

市值：3,725.42萬

市盈率：-2.12

高：1.015

開：0.980

低：0.980

收：0.980

52周最高：2.090

52周最低：0.370

股本：3,670.36萬

流通股本：2,777.08萬

量比：0.04

換手率：0.06%

股息：- -

股息率：- -

每股收益(TTM):-0.479

每股收益(LYR):-0.479

淨資產收益率：-268.15%

總資產收益率：-78.85%

市淨率：7.46

市盈率(LYR):-2.12

資料載入中...

總覽公司新聞資訊公告

Oncosil Medical向FDA提交審批申請

Oncosil Medical宣佈暫停交易待公布Tripp-Ffx試驗結果及FDA通訊

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/OSL.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSL.AU\",,,,,undefined,":{"symbol":"OSL.AU","market":"AU","secType":"STK","nameCN":"ONCOSIL MEDICAL LTD","latestPrice":1.015,"timestamp":1789452720000,"preClose":0.98,"halted":0,"volume":16425,"delay":0,"changeRate":0.035714285714285636,"nameEN":"ONCOSIL MEDICAL LTD","floatShares":27770751,"shares":36703600,"eps":-0.479499,"marketStatus":"未開盤","change":0.035,"latestTime":"09-15 16:12:00 AEST","open":0.98,"high":1.015,"low":0.98,"amount":16342,"amplitude":0.035714,"askPrice":1.04,"askSize":4345,"bidPrice":0.995,"bidSize":5444,"shortable":3,"etf":0,"ttmEps":-0.479499,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.98,"openAndCloseTimeList":[[1789430400000,1789452000000]],"volumeRatio":0.037785,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"OSL.AU","preClose":0.98,"auctionPrice":0.98,"auctionVolume":25,"auction":3,"marketStatus":"盘后竞价","timestamp":1789452480805}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSL.AU\",,,,,undefined,":{"symbol":"OSL.AU","floatShares":27770751,"roa":"-78.85%","roe":"-268.15%","lyrEps":-0.4795,"volumeRatio":0.037785,"shares":36703600,"dividePrice":0,"high":1.015,"amplitude":0.035714,"preClose":0.98,"low":0.98,"week52Low":0.37,"pbRate":"7.46","psRate":"7.32","week52High":2.09,"institutionHeld":0,"latestPrice":1.015,"committee":0.112269,"eps":-0.479499,"divideRate":0,"volume":16425,"delay":0,"ttmEps":-0.479499,"open":0.98,"prevYearClose":0.97,"prevWeekClose":0.975,"prevMonthClose":1.15,"prevQuarterClose":0.71,"fiveDayClose":1.065,"twentyDayClose":1.15,"sixtyDayClose":0.59,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-06-03","symbol":"OSL.AU","defaultRemindTime":1748908800000,"type":"split","dateTimestamp":1748872800000,"forFactor":400,"toFactor":1,"ratio":400},{"market":"AU","date":"2022-05-05","symbol":"OSL.AU","defaultRemindTime":1651708800000,"type":"split","dateTimestamp":1651672800000,"forFactor":987878,"toFactor":1000000,"ratio":0.987878}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSL.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1184214672","title":"Oncosil Medical向FDA提交審批申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1184214672","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184214672?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 16:53","pubTimestamp":1783414416,"startTime":"0","endTime":"0","summary":"Oncosil Medical Ltd已正式向美国食品药品监督管理局（FDA）提交了其设备的商业上市审批申请，标志着该产品正式进入FDA的审查阶段。\n根据流程，FDA预计将在收到提交材料后的45天内完成审查。这一关键步骤的推进，对于该公司未来的商业化进程至关重要。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","OSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161454467","title":"Oncosil Medical宣佈暫停交易 待公布Tripp-Ffx試驗結果及FDA通訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1161454467","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161454467?lang=zh_tw&edition=fundamental","pubTime":"2026-06-04 07:10","pubTimestamp":1780528225,"startTime":"0","endTime":"0","summary":"Oncosil Medical宣布暂停交易，等待公布其Tripp-Ffx临床试验结果以及与美国食品药品监督管理局的相关通讯内容。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSL.AU","BK7508","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}